Position | Company | Period |
---|
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-12-26 | 2023-12-21 |
Syros Pharmaceuticals Inc
(SYRS)
|
B Purchase |
904,977
+102.7%
4.423,999,998 USD |
904,977 +102.7% | 4.42 | 3,999,998 USD | |
2023-10-18 | 2023-10-16 |
Scholar Rock Holding Corp
(SRRK)
|
B Purchase |
2,189,781
+47.6%
6.8515,000,000 USD |
2,189,781 +47.6% | 6.85 | 15,000,000 USD | |
2023-02-16 | 2023-02-14 |
Mineralys Therapeutics Inc
(MLYS)
|
B Purchase |
937,500
+26.2%
16.0015,000,000 USD |
937,500 +26.2% | 16.00 | 15,000,000 USD | |
2022-06-01 | 2022-05-27 |
Aduro Biotech Inc
(ADRO)
|
B Purchase |
570,000
+12.4%
14.007,980,000 USD |
570,000 +12.4% | 14.00 | 7,980,000 USD | |
2021-11-17 | 2021-11-15 |
Aduro Biotech Inc
(ADRO)
|
B Purchase |
1,215,000
+36.0%
14.0017,010,000 USD |
1,215,000 +36.0% | 14.00 | 17,010,000 USD | |
2021-03-12 | 2021-03-12 | B Purchase |
147,000
+29.8%
21.293,129,630 USD |
147,000 +29.8% | 21.29 | 3,129,630 USD | ||
2021-03-12 | 2021-03-10 | B Purchase |
16,559
+3.5%
21.55356,846 USD |
16,559 +3.5% | 21.55 | 356,846 USD | ||
2021-03-12 | 2021-03-10 | B Purchase |
73,441
+18.2%
20.831,529,776 USD |
73,441 +18.2% | 20.83 | 1,529,776 USD | ||
2020-08-19 | 2020-08-18 |
Syros Pharmaceuticals Inc
(SYRS)
|
PS Planned sale |
158,583
-11.1%
13.102,076,724 USD |
158,583 -11.1% | 13.10 | 2,076,724 USD | |
2020-08-19 | 2020-08-17 |
Syros Pharmaceuticals Inc
(SYRS)
|
PS Planned sale |
744
-0.1%
13.009,672 USD |
744 -0.1% | 13.00 | 9,672 USD | |
2020-07-06 | 2020-07-01 |
Syros Pharmaceuticals Inc
(SYRS)
|
PS Planned sale |
4,627
-0.3%
11.0150,966 USD |
4,627 -0.3% | 11.01 | 50,966 USD | |
2020-06-25 | 2020-06-25 |
Syros Pharmaceuticals Inc
(SYRS)
|
PS Planned sale |
54,972
-3.7%
11.15612,850 USD |
54,972 -3.7% | 11.15 | 612,850 USD | |
2020-06-25 | 2020-06-24 |
Syros Pharmaceuticals Inc
(SYRS)
|
PS Planned sale |
48,775
-3.2%
11.07539,788 USD |
48,775 -3.2% | 11.07 | 539,788 USD | |
2020-06-25 | 2020-06-23 |
Syros Pharmaceuticals Inc
(SYRS)
|
PS Planned sale |
50,953
-3.2%
11.11565,930 USD |
50,953 -3.2% | 11.11 | 565,930 USD | |
2020-05-07 | 2020-05-05 |
Seagen Inc
(SGEN)
|
S Sale |
8,500
-17.5%
167.261,421,710 USD |
8,500 -17.5% | 167.26 | 1,421,710 USD | |
2019-04-11 | 2019-04-09 |
Syros Pharmaceuticals Inc
(SYRS)
|
B Purchase |
533,332
+50.3%
7.503,999,990 USD |
533,332 +50.3% | 7.50 | 3,999,990 USD | |
2019-02-21 | 2019-02-19 | PS Planned sale |
23,438
-10.0%
128.783,018,346 USD |
23,438 -10.0% | 128.78 | 3,018,346 USD |